source
- Hims & Hers pivots to branded GLP-1 drugs after striking deal with Eli LillyHims & Hers, which previously emphasized personalized care through compounded products, is changing its business model. The company is now focusing on established brand-name GLP-1 treatments rathe…
- ‘They’ve been misdiagnosed for too long’: Researchers use 10-protein panel to improve ALS detectionBy the time a neurodegenerative condition has been diagnosed, it's often too late. At the point of detection, the disease may already be causing irreversible damage, fueling an urgent search for wa…Fierce Biotech · 2d ago↗ source